TGFB1 and neoplasm: In a pancreatic ductal adenocarcinoma model, Meng et al. developed PEGylated liposomes with TGF-β inhibitors and observed a decrease in pericyte coverage of the tumor vasculature, which allowed higher access of liposomes to the tumor site [159].